Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-06-01 | Iconovo | Iconovo provides increased opportunities for customers in its Novel Pharmaceuticals business segment to finance innovative development projects | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Iconovo provides increased opportunities for customers in its Novel Pharmaceuticals business segment to finance innovative development projectsIconovo AB (publ), which develops complete inhalation products for a global market, today announces that the company strengthens its customer offering in the Novel Pharmaceuticals business segment by the launch of Iconovo Accelerator Program – a structured approach for pharmaceutical companies to obtain non-dilutive funding of commercially attractive projects. This is made possible through a newly established collaboration with the consulting firm Argentum, which specializes in structuring and managing application processes for EU funding and has so far helped secure over SEK 20 billion in research and development funding for its clients. The purpose of Iconovo Accelerator Program is to finance projects that are to a significant extent performed by Iconovo, which in turn can contribute to an increased earnings capacity for the company. Sales of medicines and vaccines for diseases where inhalers can provide significant benefits amount to almost USD 100 billion. Asthma, COPD, pulmonary hypertension and several types of vaccinations are some examples. Iconovo has already established four collaboration agreements in the Novel Pharmaceutical business segment, where it assists R&D-driven pharmaceutical companies in the development of completely new treatments based on the company’s unique proprietary inhalers. There are however challenges in financing new innovative pharmaceutical projects, and many smaller companies lack access to expertise that can optimize opportunities to benefit from the substantial research grants awarded each year by the EU. Iconovo Accelerator Program is launched to offer customers strategic and operational support in connection with application processes for public funding of projects that are based on the company’s inhaler platforms. ”Many customers in our Novel Pharmaceuticals business segment request professional support in their processes for seeking EU funding to their development projects, and we are proud to have established a qualified process to accelerate the development of new inhalation products. By strengthening our customers’ financing capacity, we enhance the conditions for implementing collaborative projects in a time-efficient and professional manner. This in turn has potential to increase our earnings capacity,” says Johan Wäborg, CEO of Iconovo. About Argentum |
||||
2023-06-01 | Iconovo | Iconovo ökar möjligheterna för kunder inom affärsområdet originalläkemedel att finansiera innovativa utvecklingsprojekt | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-26 | Iconovo | Kommuniké från årsstämma i Iconovo AB den 22 maj 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-26 | Iconovo | BioStock: Iconovo initiates structured sales process for ICOpre | Pressreleaser | Visa Stäng |
|
||||
2023-05-26 | Iconovo | BioStock: Iconovo inleder strukturerad säljprocess för ICOpre | Pressreleaser | Visa Stäng |
|
||||
2023-05-23 | Iconovo | Carl Lindgren new board member of Iconovo | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-23 | Iconovo | Carl Lindgren ny styrelseledamot i Iconovo | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-22 | Iconovo | Iconovo initiates structured process for out-licensing of ICOpre with a global investment bank | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-22 | Iconovo | Iconovo inleder strukturerad process för utlicensiering av ICOpre i samarbete med global investmentbank | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-15 | Iconovo | BioStock: Iconovo's oxytocin treatment in clinical phase I study | Pressreleaser | Visa Stäng |
|
||||
2023-05-15 | Iconovo | BioStock: Iconovos oxytocinbehandling i klinisk fas I-studie | Pressreleaser | Visa Stäng |
|
||||
2023-05-11 | Iconovo | Iconovo’s partner Monash University has initiated a phase I clinical trial on inhaled oxytocin in ICOone® | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-11 | Iconovo | Iconovos partner, Monash University har inlett en klinisk fas I-studie av inhalerat oxytocin i ICOone® | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-02 | Penser Access | Penser Access: Avtal för ICOone - Iconovo | Pressreleaser | Visa Stäng |
|
||||
2023-05-02 | Penser Access | Penser Access: Intervju med Iconovo - Erik Penser Bank - 2 maj 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-04-28 | Iconovo | Rättelse: DELÅRSRAPPORT JANUARI - MARS 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-28 | Iconovo | Genomförd riktad emission på 55 MSEK stärker bolaget | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-28 | Iconovo | ICONOVO AB PUBLICERAR ÅRSREDOVISNING FÖR 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-20 | Iconovo | Kallelse till årsstämma i Iconovo AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-14 | Iconovo | Iconovo receives new patent in Japan for its ICOone® inhaler platform | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-14 | Iconovo | Iconovo erhåller nytt patent i Japan för sin inhalatorplattform ICOone® | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-04 | Iconovo | BioStock: Arcede Pharma och Iconovo erhåller finansiering från Swelife | Pressreleaser | Visa Stäng |
|
||||
2023-04-04 | Iconovo | BioStock: Arcede Pharma and Iconovo receive funding from Swelife | Pressreleaser | Visa Stäng |
|
||||
2023-04-04 | Iconovo | Iconovo to evaluate ICOone Nasal for the development of antiviral nasal inhalation product | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-04 | Iconovo | Iconovo utvärderar ICOone Nasal för utveckling av antiviral nasal inhalationsprodukt | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-31 | Iconovo | Iconovo, Arcede Pharma AB och Lunds universitet erhåller finansiering från Swelife för utveckling av en ny behandling mot KOL och svår astma | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-16 | Iconovo | Iconovo Pharma har beviljats partihandelstillstånd av Läkemedelsverket | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-15 | Penser Access | Penser Access: Inhalationsplattformarna klara - Iconovo | Pressreleaser | Visa Stäng |
|
||||
2023-02-14 | Iconovo | BioStock: Iconovo carries out directed share issue for continued value creation | Pressreleaser | Visa Stäng |
|
||||
2023-02-14 | Iconovo | BioStock: Iconovo genomför riktad emission för fortsatt värdeskapande | Pressreleaser | Visa Stäng |
|
||||
2023-02-10 | Iconovo | Iconovos vd förvärvar aktier för 500 000 SEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-09 | Iconovo | Iconovos styrelseledamot och största ägare förvärvar aktier för 3 000 000 SEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | Iconovo AB has completed a directed new share issue of SEK 55 million | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | Iconovo AB har genomfört en riktad nyemission om 55 miljoner SEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | BOKSLUTSKOMMUNIKÉ 1 JANUARI – 31 DECEMBER 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | YEAR-END REPORT JANUARY-DECEMBER 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | Iconovo AB evaluates the conditions to carry out a directed new share issue of approximately SEK 50 million and brings forward publication of the year-end report for the financial year 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | Iconovo AB utreder förutsättningarna för att genomföra en riktad nyemission om cirka 50 miljoner SEK och tidigarelägger offentliggörande av bokslutskommunikén avseende räkenskapsåret 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-03 | Iconovo | Iconovo meddelar positiva resultat i interimsrapport från projekt med ICOone Nasal® | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-02-03 | Iconovo | Iconovo announces positive results in interim report from project with ICOone Nasal® | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-01-26 | Iconovo | Iconovo erhåller nytt europeiskt patent för sin engångsinhalator ICOone | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-01-26 | Iconovo | Iconovo receives approval of new European patent for its single-use inhaler ICOone® | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-01-17 | Iconovo | BioStock: Iconovo starts 2023 with negotiations for ICOpre | Pressreleaser | Visa Stäng |
|
||||
2023-01-17 | Iconovo | BioStock: Iconovo inleder 2023 med förhandlingar för ICOpre | Pressreleaser | Visa Stäng |
|
||||
2023-01-11 | Iconovo | Iconovo har inlett förhandlingar med ett globalt läkemedelsföretag om ett potentiellt licensavtal för sin inhalator ICOpre® | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-15 | Iconovo | Iconovo utser Henrik Damkjær Simonsen till Chief Financial Officer | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-15 | Iconovo | Iconovo appoints Henrik Damkjær Simonsen as Chief Financial Officer | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-07 | Iconovo | Iconovo's ICOone® inhaler platform receives new patent approval in the US | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-07 | Iconovo | Iconovos inhalatorplattform ICOone® erhåller nytt patentgodkännande i USA | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-05 | Iconovo | BioStock: Iconovo satsar på läkemedelsförsäljning i Norden | Pressreleaser | Visa Stäng |
|
||||
2022-12-05 | Iconovo | BioStock: Iconovo establishes Nordic pharmaceutical sales | Pressreleaser | Visa Stäng |
|
||||
2022-11-16 | Iconovo | Iconovo utser Peter Åkerlund till tillförordnad CFO | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-08 | Iconovo | Valberedning utsedd Iconovo | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-08 | Iconovo | Nomination Committee appointed at Iconovo | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-08 | Iconovo | BioStock: Iconovo reports Q3 and arranges pandemic event | Pressreleaser | Visa Stäng |
|
||||
2022-11-08 | Iconovo | BioStock: Iconovo rapporterar Q3 och arrangerar pandemievent | Pressreleaser | Visa Stäng |
|
||||
2022-11-04 | Penser Access | Penser Access: Intervju med Iconovo - Erik Penser Bank - 3 nov 2022 | Analyser | Visa Stäng |
|
||||
2022-11-03 | Iconovo | Abbreviated interim report 1 January - 30 September | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-31 | Penser Access | Penser Access: Leverans av nya avtal på väg - Iconovo | Analyser | Visa Stäng |
|
||||
2022-10-28 | Iconovo | DELÅRSRAPPORT 1 JANUARI – 30 SEPTEMBER 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-24 | Iconovo | BioStock: Founder and CTO on Iconovo's journey | Pressreleaser | Visa Stäng |
|
||||
2022-10-24 | Iconovo | BioStock: Iconovos grundare och CTO om bolagets resa | Pressreleaser | Visa Stäng |
|
||||
2022-10-24 | Iconovo | Iconovos unika engångsinhalator ICOone® Nasal erhöll goda omdömen i användarstudie | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-24 | Iconovo | Iconovo's unique single dose inhaler ICOone® Nasal received high marks in user study | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-12 | Iconovo | Iconovos Chief Financial Officer kommer att lämna bolaget under fjärde kvartalet 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-08-12 | Iconovo | BioStock: Iconovos vd om anslaget från Bill & Melinda Gates Foundation | Pressreleaser | Visa Stäng |
|
||||
2022-07-26 | Iconovo | Iconovo receives USD 883,800 grant from recognized international foundation to develop inhaled therapy with ICOone Nasal for the next pandemic | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-07-26 | Iconovo | Iconovo får 9 MSEK i anslag från ansedd internationell stiftelse för att utveckla inhalerade terapier baserade på ICOone Nasal inför nästa pandemi | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-07-18 | Iconovo | Abbreviated interim report 1 January - 30 June 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-07-15 | Penser Access | Penser Access: Q2-rapport andas optimism - Iconovo | Analyser | Visa Stäng |
|
||||
2022-07-15 | Iconovo | Delårsrapport 1 januari - 30 juni 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-06-20 | Iconovo | BioStock: Iconovo höjer ribban i sina finansiella mål | Pressreleaser | Visa Stäng |
|
||||
2022-06-16 | Penser Access | Penser Access: Dags för djup inandning - Iconovo | Analyser | Visa Stäng |
|
||||
2022-06-13 | Iconovo | Iconovo får ytterligare patent godkänt för ICOres® i EU | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-06-13 | Iconovo | Iconovo receives approval of additional patent for ICOres® in the EU | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-06-07 | Iconovo | Iconovo erhåller förhandsgodkännande av sitt första patent för ICOone® i Japan | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-06-07 | Iconovo | First patent granted in Japan for Iconovo’s ICOone | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-06-03 | Iconovo | Iconovo updates its long-term financial targets – expects strong revenue growth with a high margin | Analyser | Ladda ner | Visa Stäng |
|